ADVB Stock — Advanced Biomed Inc.: Metrics

Market overview

2 metrics

Share price

$10.44

Market cap

$13.06M

Price action

19 metrics

Price change (1W)

+13.7%

Price change (30D)

+37.2%

Price change (3M)

+136.5%

Price change (6M)

+145.1%

Price change (YTD)

—

Price change (1Y)

—

Trailing year

Price change (5Y)

—

52-week high

—

52-week low

—

Change from 52-week high

—

Change from 52-week low

—

Annualized volatility

212.2%

Beta

-1.6

RSI (14D)

60.1

Price vs SMA 50

+32.7%

Price vs SMA 200

—

Avg volume (3M)

1.74M

Relative volume

0.2

Average dollar volume

$19.01M

Company

3 metrics

Sector

Healthcare

Industry

Diagnostics & Research

Shares outstanding

1.38M

Valuation

12 metrics

P / E (TTM)

2.2

Trailing earnings · reciprocal yield 45.7%

PEG ratio

—

EV / revenue

—

EV / EBITDA

—

EV / EBIT

—

P / sales

—

P / book

1.4

reciprocal yield 70.5%

FCF yield

—

TTM · current market cap

Buyback yield

—

P / FCF

—

P / operating cash flow

—

Earnings yield

40.4%

Historical valuation

8 metrics

P / E historical average (3Y)

—

P / E historical average (5Y)

—

EV / revenue historical average (3Y)

—

EV / revenue historical average (5Y)

—

EV / EBIT historical average (3Y)

—

EV / EBIT historical average (5Y)

—

EV / EBITDA historical average (3Y)

—

EV / EBITDA historical average (5Y)

—

Dividends & buybacks

7 metrics

Dividend yield

—

Trailing 12 months

Payout ratio

—

Shareholder yield

—

Dividend / share (TTM)

—

Dividend growth YoY

—

Dividend growth streak

—

Last ex-dividend

—

Earnings calendar

2 metrics

Next earnings

—

Last earnings

—

Profitability

9 metrics

Gross margin

—

Operating margin

—

Trailing 12 months

Net margin

—

Gross profit (TTM)

—

Operating profit (TTM)

—

Net income (TTM)

$5.28M

Trailing 12 months

Diluted EPS (TTM)

$4.77

FCF margin

—

Effective tax rate

—

Per share

11 metrics

Revenue per diluted share (TTM)

—

Gross profit per diluted share (TTM)

—

Operating profit per diluted share (TTM)

—

EBITDA per diluted share (TTM)

—

Net income per diluted share (TTM)

—

Operating cash flow per diluted share (TTM)

—

Free cash flow per diluted share (TTM)

—

Capital expenditures per diluted share (TTM)

—

R&D per diluted share (TTM)

—

Stock compensation per diluted share (TTM)

—

Book value per share

$6.66

Growth

11 metrics

Revenue growth YoY

—

Year over year

Net income growth YoY

—

Revenue (TTM)

—

Trailing 12 months

EPS growth YoY

—

Shares change YoY

+25.5%

Year over year · more shares

Revenue CAGR (3Y)

—

Revenue CAGR (5Y)

—

EPS CAGR (3Y)

—

EPS CAGR (5Y)

—

FCF CAGR (3Y)

—

FCF CAGR (5Y)

—

Quality

14 metrics

Return on equity

57.3%

Return on assets

49.6%

Debt / equity

—

Current ratio

7.4

EBITDA (TTM)

—

Free cash flow (TTM)

—

Quick ratio

7.4

Interest coverage

—

Net debt / EBITDA

—

Return on invested capital

—

Trailing 12 months

Net cash

$2.60M

Latest balance sheet

Cash & equivalents

$2.60M

Total assets

$10.65M

Total debt

—

Cash flow & spend

7 metrics

Operating cash flow (TTM)

−$2.91M

Capital expenditures (TTM)

—

R&D (TTM)

$961,254

SG&A (TTM)

—

Stock compensation (TTM)

—

R&D / revenue

—

Stock compensation / revenue

—

Ownership (13F)

3 metrics

13F filers

—

13F filer change QoQ

—

Institutional ownership

—

Short interest

3 metrics

Short interest

2.7%

Latest settlement · 1.0 days to cover

Days to cover

1.0d

Short-squeeze score

45 / 100

Insider activity

2 metrics

Net insider buying (90D)

—

Insider-sentiment score

—

Risk flags

1 metrics

Going concern

—

ADVB · Advanced Biomed Inc.

ADVB metrics

Market overview

Price action

Company

Valuation

Historical valuation

Dividends & buybacks

Earnings calendar

Profitability

Growth

Quality

Cash flow & spend

Ownership (13F)

Short interest

Insider activity

Risk flags

No metrics match that search